BECN1 haploinsufficiency is considered one of tumorigenesis pathways in breast cancer (Vega-Rubín-de-Celis 2019), thus it is expected to be expressed at lower levels in tumor tissues than in normal ones. This evidence concerns the gene BECN1 and neoplasm.